Bristol-Myers Squibb Company Ce (CELG-RI) Research

Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological processes), and specialized chimeric antigen receptor (CAR-T) cell therapies. The company was established in August 1933 and maintains its corporate headquarters in Princeton, New Jersey.

Market snapshot

Symbol
CELG-RI
Price
$0.11
Day change
-1.34%
Market cap
$47.0B
P/E ratio
11.63x
52-week range
0.1005-0.12
Sector
Healthcare
Industry
Drug Manufacturers - General
Next earnings
in 1 month

Peer companies

  • Amgen Inc. (AMGN)
  • CVS Health Corporation (CVS)
  • Gilead Sciences, Inc. (GILD)
  • GSK plc (GSK)
  • HCA Healthcare, Inc. (HCA)
  • McKesson Corporation (MCK)
  • Medtronic plc (MDT)
  • Pfizer Inc. (PFE)

Recent insider activity

  • VESSEY RUPERT — A-Award (24209 shares) on 2019-11-20
  • VESSEY RUPERT — A-Award (13906 shares) on 2019-11-20
  • VESSEY RUPERT — A-Award (8634 shares) on 2019-11-20
  • VESSEY RUPERT — D-Return (11384 shares) on 2019-11-20
  • VESSEY RUPERT — D-Return (18257 shares) on 2019-11-20

Open Bristol-Myers Squibb Company Ce (CELG-RI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.